Epix anxiety drug fails to meet target
The drug did not show any improvement in patients compared to placebo and failed to reach the expected results. Epix suggested the outcome may have been affected by
WellSpan Health and Johns Hopkins Medicine have renewed their oncology collaboration, aiming to widen patient access to advanced care, clinical expertise, and research initiatives throughout central Pennsylvania, US.